Loyola University Health System

Oncology & Cancer

New leukemia drug is more effective and easier to use

A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL).

Diseases, Conditions, Syndromes

Researchers produce six antibodies to combat Zika virus

Researchers have generated six Zika virus antibodies that could be used to test for and possibly treat a mosquito-borne disease that has infected more than 1.5 million people worldwide.

page 3 from 40